Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins

被引:53
|
作者
Gerlach, JT
Ulsenheimer, A
Grüner, NH
Jung, MC
Schraut, W
Schirren, CA
Heeg, M
Scholz, S
Witter, K
Zahn, R
Vogler, A
Zachoval, R
Pape, GR
Diepolder, HM
机构
[1] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[2] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-81377 Munich, Germany
[3] Univ Munich, Inst Immunol, D-80336 Munich, Germany
[4] Univ Munich, Immunogenet Lab, Kinderpoliklin, D-80336 Munich, Germany
关键词
D O I
10.1128/JVI.79.19.12425-12433.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The hepatitis C virus (HCV)-specific CD4(+) T-cell response against nonstructural proteins is strongly associated with successful viral clearance during acute hepatitis C. To further develop these observations into peptide-based vaccines and clinical immunomonitoring tools like HLA class II tetramers, a detailed characterization of immunodominant CD4(+) T-cell epitopes is required. We studied peripheral blood mononuclear cells from 20 patients with acute hepatitis C using 83 overlapping 20-mer peptides covering the NS3 helicase and NS4. Eight peptides were recognized by >= 40% of patients, and specific CD4(+) T-cell clones were obtained for seven of these and three additional, subdominant epitopes. Mapping of minimal stimulatory sequences defined epitopes of 8 to 13 amino acids in length, but optimal T-cell stimulation was observed with 10- to 15-mers. While some epitopes were presented by different HLA molecules, others were presented by only a single HLA class If molecule, which has implications for patient selection in clinical trials of peptide-based immunotherapies. In conclusion, using two different approaches we identified and characterized a set of CD4(+) T-cell epitopes in the HCV NS3-NS4 region which are immunodominant in patients achieving transient or persistent viral control. This information allows the construction of a valuable panel of HCV-specific HLA class II tetramers for further study of CD4(+) T-cell responses in chronic hepatitis C. The finding of immunodominant epitopes with very constrained HLA restriction has implications for patient selection in clinical trials of peptide-based immunotherapies.
引用
收藏
页码:12425 / 12433
页数:9
相关论文
共 50 条
  • [31] Genetic immunization against the nonstructural proteins NS3, NS4 and NS5 of hepatitis C virus generates broad based cellular and humoral immune responses and protection in a tumor model.
    Encke, J
    Putlitz, JZ
    Geissler, M
    Wands, JR
    HEPATOLOGY, 1998, 28 (04) : 465A - 465A
  • [32] Erratum to:Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques
    Katherine M. Mladinich
    Shari M. Piaskowski
    Richard Rudersdorf
    Christopher M. Eernisse
    Kim L. Weisgrau
    Mauricio A. Martins
    Jessica R. Furlott
    Charalambos D. Partidos
    Joseph N. Brewoo
    Jorge E. Osorio
    Nancy A. Wilson
    Eva G. Rakasz
    David I. Watkins
    Immunogenetics, 2012, 64 : 259 - 260
  • [33] Experimental trials of predicted CD4+ and CD8+ T-cell epitopes of respiratory syncytial virus
    Naqvi, Syeda Tahira Qousain
    Muhammad, Syed Aun
    Guo, Jinlei
    Zafar, Sidra
    Ali, Amjad
    Anderson, Larry J.
    Rostad, Christina A.
    Bai, Baogang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [34] DENGUE VIRUS-SPECIFIC, HUMAN CD4+ CD8- CYTOTOXIC T-CELL CLONES - MULTIPLE PATTERNS OF VIRUS CROSS-REACTIVITY RECOGNIZED BY NS3-SPECIFIC T-CELL CLONES
    KURANE, I
    BRINTON, MA
    SAMSON, AL
    ENNIS, FA
    JOURNAL OF VIROLOGY, 1991, 65 (04) : 1823 - 1828
  • [35] Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C
    Chiang, BL
    Yang, PM
    Hwang, LH
    Wang, JM
    Kao, SF
    Pan, CH
    Chi, WK
    Chen, PJ
    Chen, DS
    JOURNAL OF BIOMEDICAL SCIENCE, 1998, 5 (04) : 290 - 296
  • [36] CD4+/CD7+ and CD4+/CD7- as T-cell immunophenotypes during chronic C hepatitis
    Perrella, A
    Tarantino, G
    Conca, P
    Sorrentino, P
    Ragucci, P
    D'Avanzo, E
    Perrella, D
    GASTROENTEROLOGY, 2002, 122 (04) : A677 - A678
  • [37] Virus-specific effector CD4+ T-Cell responses in hemodialysis patients with hepatitis C virus infection
    Rico, MA
    Ruiz, S
    Subirá, D
    Barril, G
    Cigarrán, S
    Castañón, S
    Quiroga, JA
    Selgas, R
    Carreño, V
    JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (01) : 66 - 74
  • [38] THE HEPATITIS C VIRUS ENHANCES ACTIVATION OF THE EGF-RECEPTOR AND AKT-ACTIVITY BY NS3/4A-MEDIATED CLEAVAGE OF THE T-CELL PROTEIN TYROSINE PHOSPHATASE
    Brenndoerfer, E.
    Karthe, J.
    Frelin, L.
    Cebula, P.
    Erhardt, A.
    Hengel, H.
    Bartenschlager, R.
    Sallberg, M.
    Haeussinger, D.
    Bode, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S124 - S124
  • [39] Humoral and CD4+ T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein:: NS3 primes Th 1-like responses more effectively as a DNA-based immunogen than as a recombinant protein
    Lazdina, U
    Hultgren, C
    Frelin, L
    Chen, M
    Lodin, K
    Weiland, O
    Leroux-Roels, G
    Quiroga, JA
    Peterson, DL
    Milich, DR
    Sällberg, M
    JOURNAL OF GENERAL VIROLOGY, 2001, 82 : 1299 - 1308
  • [40] Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals:: implications for prophylactic vaccine
    Li, Wen
    Krishnadas, Deepa K.
    Kumar, Rakesh
    Tyrrell, D. Lorne J.
    Agrawal, Babita
    INTERNATIONAL IMMUNOLOGY, 2008, 20 (01) : 89 - 104